skip to main content

Yellow Card reporting — GPhC CRA MCQ

Instant feedback + full explanation. One question, done properly.

HardAdverse Drug Reactions and Drug SafetyYellow Card reportingGPhC CRA

A patient develops a widespread rash two days after starting a newly marketed medicine. The prescriber has stopped the medicine and asks whether the pharmacy should report it. What is the most appropriate action?

Educational content. Not a substitute for clinical judgement or local policy.

Reveal the answer and explanation

Correct answer: C — Submit a Yellow Card report for the suspected adverse reaction

Suspected adverse reactions to medicines, especially serious reactions or those involving newer medicines, should be reported through the Yellow Card scheme. Causality does not need to be proven before reporting. The PMR should accurately document the suspected reaction. Waiting for rechallenge could expose the patient to avoidable harm.

Reference: MHRA Yellow Card; GPhC Standards